Network origin in Harald Haubitz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
31
| Subsidiary | Pharmaceuticals: Major | 31 |
| Subsidiary | Pharmaceuticals: Major | 15 | |
Cimex AG
2
| Extinct | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Harald Haubitz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO Chairman Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| University of Basel | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer Compliance Officer | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
| Friends of Phelophepa Foundation | Chairman Chairman | ||
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member | |
| EPIGENOMICS AG | Medical Specialties | Director/Board Member Chairman | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Human Resources Officer | |
| University of Innsbruck | College/University | Doctorate Degree Doctorate Degree | |
TeGenero AG
 TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Humer Foundation | Chairman Director/Board Member | ||
| SPEXIS AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| BACHEM HOLDING AG | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Founder Chairman | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Freiburg | College/University | Corporate Officer/Principal Doctorate Degree | |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Chairman | |
| DIUL GROUP | Pharmaceuticals: Major | Chairman | |
| BRAIN+ A/S | Packaged Software | Chairman | |
| Association For Cancer Immunotherapy | Corporate Officer/Principal | ||
| ADAMA AGRICULTURAL SOLUTIONS LTD | Chemicals: Agricultural | Corporate Officer/Principal | |
| PHILIPS NV | Medical Specialties | Director/Board Member | |
| QIAGEN N.V. | Medical Specialties | Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Chief Executive Officer | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Härfstrand Consulting AG
 Härfstrand Consulting AG Miscellaneous Commercial ServicesCommercial Services Härfstrand Consulting AG provides management consulting services. The private company is based in Zug, Switzerland. The Swiss company was founded by Karl Anders Olof Härfstrand. | Miscellaneous Commercial Services | Founder | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
| PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member |
Statistics
International
| Switzerland | 14 |
| United States | 14 |
| Germany | 11 |
| United Kingdom | 3 |
| Sweden | 3 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 2 |
Operational
| Director/Board Member | 267 |
| Corporate Officer/Principal | 119 |
| Chairman | 98 |
| Chief Executive Officer | 61 |
| Independent Dir/Board Member | 53 |
Most connected contacts
| Insiders | |
|---|---|
| Franz Humer | 45 |
| Bradley Bolzon | 41 |
| Jean-Luc Bélingard | 40 |
| Erich Maximilian Platzer | 31 |
| Erich Hunziker | 28 |
| Hans-Peter Hasler | 28 |
| Gottlieb A. Keller | 26 |
| Peter Arend William Burema | 23 |
| Karl Härfstrand | 23 |
| Pamela Kirby | 22 |
| Richard T. Laube | 21 |
| Heino von Prondzynski | 19 |
| Patrick Baeuerle | 19 |
| Ulrich Winzenried | 18 |
| Andreas Rummelt | 18 |
- Stock Market
- Insiders
- Harald Haubitz
- Company connections
